Dr Claudia Bruno
The Leeder Centre for Health Policy, Economics and Data
As a pharmacoepidemiologist, I use population-based data to examine the quality use of medicines among priority populations. My research aims to promote best-practice healthcare through public health policy and clinical practice changes.
I am an early career researcher working at the Leeder Centre for Health Policy, Economics, and Data at the University of Sydney and with the Medicines Intelligence (MedIntel) Research Program at the University of New South Wales.
Throughout my career, I have conducted extensive analyses of linked health data on both national and international levels. Notably, I participated in a multinational collaboration with the Nordic countries, during an eight-month placement at the Norwegian Institute of Public Health in Oslo. This partnership enabled knowledge exchange and provided valuable insights into the safety of medicines in pregnancy and the analysis of multinational data.
I am passionate about using population-based linked data and sophisticated methods to provide evidence about real-world medicine use and outcomes. I am particularly interested in the safety and quality use of medicines among high-risk and under-served population groups, including pregnant women and children.
Linked adminstrative data
- The Gro Harlem Brundtland Visiting Scholarship, Norway,2024
- Australian Government Research Training Program Scholarship, 2020-2024
- Conference scholarship, International Society of Pharmacoepidemiology,2023 Mid-Year Meeting, Reykjavik, Iceland.
- D I McCloskey Stage 3 Physiology Prize for the highest average mark in any three Stage 3 Physiology courses by a graduand with a major in Physiology (2016)
(Norwegian Institute of Public Health) Involved in several studies focussed on research of medicine use during pregnancy and child health. NorPReSS- Nordic Pregnancy Safety Studies Research consortium Recipient of the Gro Harlem Brundtland Visiting Scholarship at the Centre for Fertility and Health |
Publications
Journals
- Bruno, C., Havard, A., Gillies, M., Coghill, D., Brett, J., Guastella, A., Pearson, S., Zoega, H. (2023). Patterns of attention deficit hyperactivity disorder medicine use in the era of new non-stimulant medicines: A population-based study among Australian children and adults (2013-2020). Australian and New Zealand Journal of Psychiatry, 57(5), 675-685. [More Information]
- Bruno, C., Havard, A., Hanly, M., Falster, K., Nassar, N., Edwards, B., Guastella, A., Pearson, S., Zoega, H. (2022). Children's Relative Age and Medicine Treatment for Attention-Deficit/Hyperactivity Disorder Across Australian Jurisdictions with Different School Enrolment Policies. Journal of Child and Adolescent Psychopharmacology, 32(6), 349-357. [More Information]
- Schaffer, A., Bruno, C., Buckley, N., Cairns, R., Litchfield, M., Paget, S., Zoega, H., Nassar, N., Pearson, S. (2022). Prescribed medicine use and extent of off-label use according to age in a nationwide sample of Australian children. Paediatric and Perinatal Epidemiology, 36(5), 726-737. [More Information]
2023
- Bruno, C., Havard, A., Gillies, M., Coghill, D., Brett, J., Guastella, A., Pearson, S., Zoega, H. (2023). Patterns of attention deficit hyperactivity disorder medicine use in the era of new non-stimulant medicines: A population-based study among Australian children and adults (2013-2020). Australian and New Zealand Journal of Psychiatry, 57(5), 675-685. [More Information]
2022
- Bruno, C., Havard, A., Hanly, M., Falster, K., Nassar, N., Edwards, B., Guastella, A., Pearson, S., Zoega, H. (2022). Children's Relative Age and Medicine Treatment for Attention-Deficit/Hyperactivity Disorder Across Australian Jurisdictions with Different School Enrolment Policies. Journal of Child and Adolescent Psychopharmacology, 32(6), 349-357. [More Information]
- Schaffer, A., Bruno, C., Buckley, N., Cairns, R., Litchfield, M., Paget, S., Zoega, H., Nassar, N., Pearson, S. (2022). Prescribed medicine use and extent of off-label use according to age in a nationwide sample of Australian children. Paediatric and Perinatal Epidemiology, 36(5), 726-737. [More Information]
- Daniels, B., Schaffer, A., Buckley, N., Bruno, C., Jun, M., Pearson, S., Zoega, H. (2022). The impact of tightened prescribing restrictions on proton pump inhibitor use in Australia: An evaluation using interrupted time series analysis. Pharmacoepidemiology and Drug Safety, 31(3), 370-378. [More Information]
2021
- Daniels, B., Pearson, S., Buckley, N., Bruno, C., Schaffer, A., Zoega, H. (2021). Coming to grips with seemingly conflicting results in programme evaluation: The devil's in the detail. BMJ Quality and Safety, 30(1), 70-71. [More Information]
- Daniels, B., Healey, P., Bruno, C., Kaan, I., Zoega, H. (2021). Medicine treatment of glaucoma in Australia 2012-2019: Prevalence, incidence and persistence. BMJ Open Ophthalmology, 6(1), e000921-1-e000921-7. [More Information]
- De Oliveira Costa, J., Bruno, C., Schaffer, A., Raichand, S., Karanges, E., Pearson, S. (2021). The changing face of Australian data reforms: Impact on pharmacoepidemiology research. International Journal of Population Data Science, 6(1), 1418. [More Information]
2020
- Daniels, B., Pearson, S., Buckley, N., Bruno, C., Zoega, H. (2020). Long-term use of proton-pump inhibitors: whole-of-population patterns in Australia 2013-2016. Therapeutic Advances in Gastroenterology, 13, 1-11. [More Information]
- Bruno, C., Pearson, S., Daniels, B., Buckley, N., Schaffer, A., Zoega, H. (2020). Passing the acid test? Evaluating the impact of national education initiatives to reduce proton pump inhibitor use in Australia. BMJ Quality and Safety, 29(5), 365-373. [More Information]